Understand the source comparison
LL-37 Lyme Support Complete Guide 2026: Comparison of Antimicrobial Mechanisms
LL-37's mechanism differs fundamentally from standard Lyme antibiotics. Understanding these differences clarifies why biofilm-embedded spirochetes evade conventional treatment. Primary Target Bacterial membrane + intracellular DNA 30S ribosomal subunit (protei
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- LL-37's mechanism differs fundamentally from standard Lyme antibiotics. Understanding these differences clarifies why biofilm-embedded spirochetes evade conventional treatment.
- Primary Target
- Bacterial membrane + intracellular DNA
- 30S ribosomal subunit (protein synthesis)
- Peptidoglycan cell wall synthesis
- Peptidoglycan cross-linking
- LL-37 targets multiple sites simultaneously. Membrane, DNA, and immune signalling
- Biofilm Penetration
- Penetrates 200–500 μm into biofilm matrix
- Poor. <50 μm effective depth
- Minimal. Relies on active cell wall synthesis
- Moderate. 100–150 μm depth
- LL-37 reaches spirochetes in deep biofilm layers that antibiotics cannot access
- Persister Cell Activity
- Active against non-replicating persisters (DNA-binding mechanism)
- Ineffective. Requires active protein synthesis
- Ineffective. Requires active cell wall synthesis
- Limited. Some persister activity at high doses
- LL-37's DNA-binding works independently of bacterial metabolic state
- Resistance Development
- Extremely low. Membrane disruption cannot be easily mutated around
- Moderate. Efflux pump upregulation common
- Moderate. Beta-lactamase production
- Low. But cross-resistance with other beta-lactams
- Physical membrane disruption prevents traditional resistance mechanisms
- Immune Modulation
- Binds LPS/LTA, reduces TNF-α and IL-6 by 55–60%
- None
- LL-37 addresses both infection and inflammatory cascade
- Effective Concentration (in vitro)
- 5–20 μg/mL against Borrelia biofilms
- 0.5–2 μg/mL against planktonic only
- 0.12–0.5 μg/mL against planktonic only
- 0.06–0.25 μg/mL
- Concentrations reflect biofilm vs planktonic efficacy gap